Further validation allowed the identification of CALR, CLIC1, IRAK4, GSTO1 and CypA as ALS biomarkers, while CypA, TDP-43 and ERp57 as biomarkers for disease progression [42]. Here, PPIA is linked to amyotrophic lateral sclerosis.